{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:39:40Z","timestamp":1772757580832,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11883-019-0776-8","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T01:10:54Z","timestamp":1552698654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["2018 Cholesterol Guidelines: Key Topics in Primary Prevention"],"prefix":"10.1007","volume":"21","author":[{"suffix":"III","given":"Donald","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,16]]},"reference":[{"key":"776_CR1","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018.","DOI":"10.1161\/CIR.0000000000000624"},{"issue":"12","key":"776_CR2","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67\u2013e492.","journal-title":"Circulation"},{"key":"776_CR3","doi-asserted-by":"crossref","unstructured":"Lloyd-Jones DM, Braun LT, Ndumele CE, et al. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2018.","DOI":"10.1161\/CIR.0000000000000638"},{"issue":"6","key":"776_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D'Agostino","year":"2008","unstructured":"D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743\u201353.","journal-title":"Circulation"},{"issue":"6","key":"776_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jama.297.6.611","volume":"297","author":"PM Ridker","year":"2007","unstructured":"Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA. 2007;297(6):611\u20139.","journal-title":"JAMA"},{"issue":"22","key":"776_CR6","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","volume":"118","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation. 2008;118(22):2243\u201351 2244p following 2251.","journal-title":"Circulation"},{"issue":"29","key":"776_CR7","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315\u201381.","journal-title":"Eur Heart J"},{"issue":"Suppl 2","key":"776_CR8","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/heartjnl-2014-305693","volume":"100","author":"J Board","year":"2014","unstructured":"Board J. Joint British Societies\u2019 consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100(Suppl 2):ii1\u2013ii67.","journal-title":"Heart"},{"issue":"8","key":"776_CR9","first-page":"598","volume":"38","author":"AP DeFilippis","year":"2017","unstructured":"DeFilippis AP, Young R, McEvoy JW, et al. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort. Eur Heart J. 2017;38(8):598\u2013608.","journal-title":"Eur Heart J"},{"key":"776_CR10","doi-asserted-by":"crossref","unstructured":"Colantonio LD, Richman JS, Carson AP, Lloyd-Jones DM, Howard G, Deng L, et al. Performance of the atherosclerotic cardiovascular disease pooled cohort risk equations by social deprivation status. J Am Heart Assoc. 2017;6(3).","DOI":"10.1161\/JAHA.117.005676"},{"issue":"2","key":"776_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamacardio.2016.4494","volume":"2","author":"MJ Feinstein","year":"2017","unstructured":"Feinstein MJ, Nance RM, Drozd DR, Ning H, Delaney JA, Heckbert SR, et al. Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: a study by the Centers for AIDS Research Network of Integrated Clinical Systems. JAMA Cardiol. 2017;2(2):155\u201362.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"776_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jacc.2015.10.058","volume":"67","author":"J Yeboah","year":"2016","unstructured":"Yeboah J, Young R, McClelland RL, et al. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol. 2016;67(2):139\u201347.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"776_CR13","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.jacc.2015.07.066","volume":"66","author":"K Nasir","year":"2015","unstructured":"Nasir K, Bittencourt MS, Blaha MJ, Blankstein R, Agatson AS, Rivera JJ, et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology\/American Heart Association cholesterol management guidelines: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol. 2015;66(15):1657\u201368.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"776_CR14","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jcmg.2012.02.017","volume":"5","author":"JW McEvoy","year":"2012","unstructured":"McEvoy JW, Blaha MJ, Rivera JJ, et al. Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification. JACC Cardiovasc Imaging. 2012;5(10):1037\u201345.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"776_CR15","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.amjcard.2014.07.043","volume":"114","author":"R Cohen","year":"2014","unstructured":"Cohen R, Budoff M, McClelland RL, et al. Significance of a positive family history for coronary heart disease in patients with a zero coronary artery calcium score (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2014;114(8):1210\u20134.","journal-title":"Am J Cardiol"},{"issue":"10","key":"776_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/hiv.12262","volume":"16","author":"TS Metkus","year":"2015","unstructured":"Metkus TS, Brown T, Budoff M, Kingsley L, Palella FJ Jr, Witt MD, et al. HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter AIDS Cohort Study (MACS). HIV Med. 2015;16(10):635\u20139.","journal-title":"HIV Med"},{"issue":"25 Suppl 2","key":"776_CR17","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","volume":"129","author":"MD Jensen","year":"2014","unstructured":"Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102\u201338.","journal-title":"Circulation"},{"issue":"9716","key":"776_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735\u201342.","journal-title":"Lancet"},{"issue":"18","key":"776_CR19","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.2165\/11638240-000000000-00000","volume":"72","author":"FM Vries de","year":"2012","unstructured":"de Vries FM, Denig P, Pouwels KB, Postma MJ, Hak E. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis. Drugs. 2012;72(18):2365\u201373.","journal-title":"Drugs"},{"issue":"9753","key":"776_CR20","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670\u201381.","journal-title":"Lancet"},{"issue":"1","key":"776_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","volume":"134","author":"AM Perak","year":"2016","unstructured":"Perak AM, Ning H, de Ferranti SD, Gooding HC, Wilkins JT, Lloyd-Jones DM. Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype. Circulation. 2016;134(1):9\u201319.","journal-title":"Circulation"},{"key":"776_CR22","doi-asserted-by":"crossref","unstructured":"Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;(1):CD004816.","DOI":"10.1002\/14651858.CD004816.pub5"},{"issue":"7","key":"776_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/CIRCULATIONAHA.114.010001","volume":"130","author":"B Doran","year":"2014","unstructured":"Doran B, Guo Y, Xu J, Weintraub H, Mora S, Maron DJ, et al. Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III). Circulation. 2014;130(7):546\u201353.","journal-title":"Circulation"},{"issue":"1","key":"776_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pcad.2018.05.004","volume":"61","author":"L Chiavaroli","year":"2018","unstructured":"Chiavaroli L, Nishi SK, Khan TA, Braunstein CR, Glenn AJ, Mejia SB, et al. Portfolio dietary pattern and cardiovascular disease: a systematic review and meta-analysis of controlled trials. Prog Cardiovasc Dis. 2018;61(1):43\u201353.","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"776_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011684","volume":"7","author":"Q Yang","year":"2017","unstructured":"Yang Q, Zhong Y, Gillespie C, Merritt R, Bowman B, George MG, et al. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study. BMJ Open. 2017;7(1):e011684.","journal-title":"BMJ Open"},{"key":"776_CR26","doi-asserted-by":"crossref","unstructured":"Egan BM, Li J, White K, Fleming DO, Connell K, Hernandez GT, et al. 2013 ACC\/AHA cholesterol guideline and implications for healthy people 2020 cardiovascular disease prevention goals. J Am Heart Assoc. 2016;5(8).","DOI":"10.1161\/JAHA.116.003558"},{"issue":"8","key":"776_CR27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","volume":"123","author":"PA Heidenreich","year":"2011","unstructured":"Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933\u201344.","journal-title":"Circulation"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-019-0776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-019-0776-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-019-0776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T21:58:36Z","timestamp":1663106316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-019-0776-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,16]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1007\/s11883-019-0776-8","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,16]]},"assertion":[{"value":"16 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Donald Clark III and Salim S. Virani declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"17"}}